Tag: BCI

Onward awarded grant to continue developing brain-computer interface technology

Onward Medical has been awarded a second grant from the European Innovation Council (EIC) to support the continued development of its brain-computer interface (BCI)...

Positive animal-model results with ABILITY BCI are “important step” towards human...

The Wyss Center for Bio and Neuroengineering in Geneva, Switzerland has today revealed the latest preclinical neural data acquired with its fully implantable ABILITY...

Synchron to begin COMMAND trial enrolment at University of Pittsburgh

Synchron has announced that enrolment in the COMMAND trial has commenced at the University of Pittsburgh in Pittsburgh, USA. The COMMAND trial is an early...
first command implant

First US Stentrode implant heralds new field in neurointerventional surgery

Following the first endovascular implantation of Synchron’s Stentrode brain-computer interface (BCI) device in the USA, physicians have highlighted the wider significance of this breakthrough...

Synchron announces first human brain-computer interface implant in the USA

Synchron has announced the first human brain-computer interface (BCI) implant in the USA. This procedure represents a significant technological milestone for scalable BCI devices...

Synchron enrols first patient in US COMMAND study of endovascular brain-computer...

Synchron has announced enrolment of the first patient in the US COMMAND clinical trial for patients with severe paralysis at Mount Sinai Hospital in...

Implantable brain-computer interface enables completely locked-in patient to communicate

Researchers at the Wyss Center for Bio and Neuroengineering (Geneva, Switzerland), in collaboration with the University of Tübingen (Tübingen, Germany), have enabled a person...
synchron stentrode safety

Synchron announces long-term safety results with Stentrode device for severe paralysis

Synchron has announced the results from a study in which four people with amyotrophic lateral sclerosis (ALS) received an implant of the company’s Stentrode...

Brain-computer interface technology opens up “whole new world” of therapies

 “We are starting to help patients in ways that we did not think were possible,” Thomas Oxley (Mount Sinai Hospital, New York, USA) tells...
synchron stentrode safety

Synchron announces US$10 million NIH grant for US COMMAND trial

The National Institutes of Health (NIH) has collectively awarded Carnegie Mellon University, University of Pittsburgh Medical Center (UPMC), Mount Sinai Health System and Synchron...

First-in-human study demonstrates use of high-bandwidth wireless brain-computer interface  

Results of the BrainGate clinical trial, published in the journal IEEE Transactions on Biomedical Engineering, detail the first-in-human use of a new wireless brain-computer interface (BCI) in patients with tetraplegia....

LIVE from SNIS: Endovascular brain-computer interface improves function in paralysed patient

According to late-breaking data presented at the Society of NeuroInterventional Surgery’s (SNIS) 17th Annual Meeting, a wireless endovascular brain–computer interface (BCI) “may improve capacity to perform activities in daily living...